Figure 5

Comparison of A-SAA derived biomarkers in patients with cirrhosis. A total of 116 serum samples from 30 LC and 86 HCC patients were measured and analyzed. Early HCC indicates BCLC stage 0-A (n = 38). Intermediate HCC indicates BCLC stage B (n = 24). Advanced HCC indicates BCLC stage C-D (n = 24). (a) Total A-SAA. (b) A-SAA monomer. (c) A-SAA oligomer. (d) PMCA signal. The statistical analysis was performed by one-way ANOVA and Tukey’s Post Hoc Test, where P < 0.05 (*), < 0.01 (**), < 0.001 (***), and < 0.0001 (****). NS not significant.